COVID-19 Pandemic and Road Ahead

Published on:November 2020
Indian Journal of Pharmacy Practice, 2020; 13(4):287
Invited Article | doi:10.5530/ijopp.13.4.49

COVID-19 Pandemic and Road Ahead

Authors and affiliation (s):

Dr. Shobha Rani R Hiremath

Principal, Al-Ameen College of Pharmacy, Bangalore, Karnataka, INDIA


Dear Readers,

Greetings of the season!

It is evident that COVID-19 cases are raising constantly in the country and worldwide. As on October 30, 2020, there were over 45 million global cases of COVID-19. Over 33 million people had recovered from the disease and the recovery rate is found to be quite satisfactory, while there had been over 1.1 million deaths.

According to healthcare professionals/ leaders, full recovery would need a month or two post COVID infection. People who recover from COVID-19 infection experience post-covid complications no matter how mild or severe the infection is. It is reported that patients have started showing health problems weeks/even months after recovering from COVID-19.

About 1 in 6 patients are showing complications, including some that are lifethreatening. Many of these complications may be caused by a condition known as cytokine release syndrome. When an infection triggers the immune system, inflammatory proteins called cytokines are released which can kill tissue and damage the organs, including lungs, heart and kidneys. Read more...


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs